These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31242692)

  • 21. Dystrophic microglia in late-onset Alzheimer's disease.
    Streit WJ; Khoshbouei H; Bechmann I
    Glia; 2020 Apr; 68(4):845-854. PubMed ID: 31922322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging.
    Bachstetter AD; Van Eldik LJ; Schmitt FA; Neltner JH; Ighodaro ET; Webster SJ; Patel E; Abner EL; Kryscio RJ; Nelson PT
    Acta Neuropathol Commun; 2015 May; 3():32. PubMed ID: 26001591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglia in Alzheimer's disease.
    Sarlus H; Heneka MT
    J Clin Invest; 2017 Sep; 127(9):3240-3249. PubMed ID: 28862638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interplay between microglial states and major risk factors in Alzheimer's disease through the eyes of single-cell RNA-sequencing: beyond black and white.
    von Maydell D; Jorfi M
    J Neurophysiol; 2019 Oct; 122(4):1291-1296. PubMed ID: 31365320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microglial pathology.
    Streit WJ; Xue QS; Tischer J; Bechmann I
    Acta Neuropathol Commun; 2014 Sep; 2():142. PubMed ID: 25257319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglial dysfunction in brain aging and Alzheimer's disease.
    Mosher KI; Wyss-Coray T
    Biochem Pharmacol; 2014 Apr; 88(4):594-604. PubMed ID: 24445162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease.
    Stansley B; Post J; Hensley K
    J Neuroinflammation; 2012 May; 9():115. PubMed ID: 22651808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease.
    Ghosh S; Geahlen RL
    EBioMedicine; 2015 Nov; 2(11):1785-98. PubMed ID: 26870803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The microglial lysosomal system in Alzheimer's disease: Guardian against proteinopathy.
    Van Acker ZP; Perdok A; Bretou M; Annaert W
    Ageing Res Rev; 2021 Nov; 71():101444. PubMed ID: 34391945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglial heterogeneity in aging and Alzheimer's disease: Is sex relevant?
    Delage CI; Šimončičová E; Tremblay MÈ
    J Pharmacol Sci; 2021 Jul; 146(3):169-181. PubMed ID: 34030799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TREM2, Microglia, and Neurodegenerative Diseases.
    Yeh FL; Hansen DV; Sheng M
    Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
    Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
    J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The VGF-derived Peptide TLQP21 Impairs Purinergic Control of Chemotaxis and Phagocytosis in Mouse Microglia.
    Elmadany N; de Almeida Sassi F; Wendt S; Logiacco F; Visser J; Haage V; Hernandez DP; Mertins P; Hambardzumyan D; Wolf S; Kettenmann H; Semtner M
    J Neurosci; 2020 Apr; 40(17):3320-3331. PubMed ID: 32060170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microglial remodeling of actin network by Tau oligomers, via G protein-coupled purinergic receptor, P2Y12R-driven chemotaxis.
    Das R; Chinnathambi S
    Traffic; 2021 May; 22(5):153-170. PubMed ID: 33527700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TMEM119 marks a subset of microglia in the human brain.
    Satoh J; Kino Y; Asahina N; Takitani M; Miyoshi J; Ishida T; Saito Y
    Neuropathology; 2016 Feb; 36(1):39-49. PubMed ID: 26250788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.
    Spangenberg EE; Green KN
    Brain Behav Immun; 2017 Mar; 61():1-11. PubMed ID: 27395435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer's Disease Brains.
    Walker DG; Tang TM; Mendsaikhan A; Tooyama I; Serrano GE; Sue LI; Beach TG; Lue LF
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microglial in neurodegenerative disorders: emphasis on Alzheimer's disease.
    McRae A; Dahlström A; Ling EA
    Gerontology; 1997; 43(1-2):95-108. PubMed ID: 8996832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglia in Alzheimer's disease.
    Hansen DV; Hanson JE; Sheng M
    J Cell Biol; 2018 Feb; 217(2):459-472. PubMed ID: 29196460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.